Related Experiment Videos

The hepatitis C self-management program: sustainability of primary outcomes at 1 year

Erik J Groessl1, Samuel B Ho, Steven M Asch

  • 11VA San Diego Healthcare System, San Diego, CA, USA.

Health Education & Behavior : the Official Publication of the Society for Public Health Education
|March 1, 2013
PubMed

Insights

A 6-week self-management workshop improved hepatitis C knowledge and quality of life for patients. These positive effects were sustained 12 months later, showing the long-term benefits of self-management interventions for chronic hepatitis C.

Area of Science:

  • Hepatology
  • Public Health
  • Behavioral Science

Background:

  • Chronic hepatitis C virus (HCV) infection impacts millions globally.
  • Antiviral treatments are effective but not suitable for all patients.
  • Self-management interventions offer a pathway to improve liver wellness and quality of life for HCV patients.

Purpose of the Study:

  • To assess the sustained effects of a 6-week HCV self-management program at a 12-month follow-up.
  • To evaluate the long-term impact of a cognitive-behavioral self-management intervention on HCV patients.

Main Methods:

  • 134 Veteran Affairs patients with hepatitis C were randomized into a 6-week self-management workshop or an information-only group.
  • Intervention involved weekly 2-hour sessions based on a cognitive-behavioral program with HCV-specific modules.
  • Outcomes measured included HCV knowledge, depression, energy, and quality of life at baseline, 6 weeks, 6 months, and 12 months.

Main Results:

  • Participants in the self-management workshop showed significant improvements in HCV knowledge (p < .005).
  • Enhanced energy/vitality (SF-36, p = .016) and quality of well-being (p = .036) were observed in the workshop group.
  • Positive trends were also noted for physical functioning and depression scores.

Conclusions:

  • The benefits of the 6-week self-management intervention were sustained at the 12-month follow-up.
  • HCV self-management programs are effective in improving patient outcomes.
  • Healthcare providers should consider integrating self-management interventions for chronic HCV patients.
Abstract

Keywords:
chronic disease managementhealth behaviorhepatitis Cpatient educationquality of life

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...